Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

National City, California


Purpose:

This study is to assess the safety and tolerability of a five-day titration schedule (using twice daily dosing for the first three days) to achieve the highest proposed dose of 40 mg daily. The study duration is two months.


Criteria:

Inclusion Criteria: - Subjects who have current diagnosis of Schizophrenia or Schizoaffective disorder - Body weight of 100-250 lbs - Male or females - 18-55 years of age Exclusion Criteria: - Subjects who are acutely psychotic - Subjects with current Axis I primary psychiatric diagnosis other than schizophrenia, at significant risk of suicide


NCT ID:

NCT00139906


Primary Contact:

Study Director
Global Clinical Director Solvay
Solvay Pharmaceuticals


Backup Contact:

N/A


Location Contact:

National City, California
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 11, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.